HERON THERAPEUTICS, INC. /DE/ Quarterly Nonoperating Income (Expense) in USD from Q1 2014 to Q4 2020

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Heron Therapeutics, Inc. /De/ annual/quarterly Nonoperating Income (Expense) history and growth rate from Q1 2014 to Q4 2020.
  • Heron Therapeutics, Inc. /De/ Nonoperating Income (Expense) for the quarter ending December 31, 2020 was -$985K, a 168% decline year-over-year.
  • Heron Therapeutics, Inc. /De/ Nonoperating Income (Expense) for the twelve months ending December 31, 2020 was $885K, a 85.1% decline year-over-year.
  • Heron Therapeutics, Inc. /De/ annual Nonoperating Income (Expense) for 2023 was $56K.
  • Heron Therapeutics, Inc. /De/ annual Nonoperating Income (Expense) for 2022 was -$7.37M, a 158% decline from 2021.
  • Heron Therapeutics, Inc. /De/ annual Nonoperating Income (Expense) for 2021 was -$2.86M, a 423% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2020 $885K -$985K -$2.43M -168% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-24
Q3 2020 $3.31M $156K -$1.1M -87.6% Jul 1, 2020 Sep 30, 2020 10-K 2021-02-24
Q2 2020 $4.41M $559K -$998K -64.1% Apr 1, 2020 Jun 30, 2020 10-K 2021-02-24
Q1 2020 $5.41M $1.16M -$533K -31.6% Jan 1, 2020 Mar 31, 2020 10-K 2021-02-24
Q4 2019 $5.95M $1.44M -$313K -17.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-24
Q3 2019 $6.26M $1.26M -$2.18M -63.4% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-24
Q2 2019 $8.43M $1.56M +$1.37M +751% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-24
Q1 2019 $7.06M $1.69M +$1.96M Jan 1, 2019 Mar 31, 2019 10-K 2021-02-24
Q4 2018 $5.1M $1.76M +$2.36M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 $2.74M $3.43M +$3.99M Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 -$1.24M $183K +$927K Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 -$2.17M -$275K +$755K +73.3% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 -$2.93M -$600K Oct 1, 2017 Dec 31, 2017 10-K 2019-02-22
Q3 2017 -$552K Jul 1, 2017 Sep 30, 2017 10-K 2019-02-22
Q2 2017 -$744K Apr 1, 2017 Jun 30, 2017 10-K 2019-02-22
Q1 2017 -$1.03M Jan 1, 2017 Mar 31, 2017 10-K 2019-02-22
Q1 2015 -$210K +$6K +2.78% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-08
Q1 2014 -$216K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.